Results 31 to 40 of about 836,416 (221)

Gene modification strategies for next-generation CAR T cells against solid cancers

open access: yesJournal of Hematology & Oncology, 2020
Immunotherapies have become the backbone of cancer treatment. Among them, chimeric antigen receptor (CAR) T cells have demonstrated great success in the treatment of hematological malignancies.
Yonggui Tian   +3 more
doaj   +1 more source

Genes Encoding the T-Cell Antigen Receptor

open access: yesJournal of Investigative Dermatology, 1985
The search for the elusive and controversial T-cell antigen receptor is over. It is now clear that gene complexes for both alpha and beta chains are distinct from those for immunoglobulin genes. They are, however, related to Ig genes as well as to other class I and class II major histocompatibility complex (MHC) gene products. Therefore, they belong to
Nicolette Caccia   +7 more
openaire   +4 more sources

Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting

open access: yesNature Communications, 2023
Chimeric antigen receptors (CARs) and synthetic Notch (synNotch) receptors are engineered cell-surface receptors that sense a target antigen and respond by activating T cell receptor signaling or a customized gene program, respectively.
Elisa Ruffo   +10 more
doaj   +1 more source

Modeling interaction of Glioma cells and CAR T-cells considering multiple CAR T-cells bindings [PDF]

open access: yesarXiv, 2022
Chimeric antigen receptor (CAR) T-cell based immunotherapy has shown its potential in treating blood cancers, and its application to solid tumors is currently being extensively investigated. For glioma brain tumors, various CAR T-cell targets include IL13Ra2, EGFRvIII, HER2, EphA2, GD2, B7-H3, and chlorotoxin.
arxiv  

Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response

open access: yesNature Communications, 2019
T cells expressing CD19-targeting chimeric antigen receptors (CARs) reveal high efficacy in the treatment of B cell malignancies. Here, we report that T cell receptor fusion constructs (TRuCs) comprising an antibody-based binding domain fused to T cell ...
P. Baeuerle   +20 more
semanticscholar   +1 more source

Gene Expression-Based Identification of Antigen-Responsive CD8+ T Cells on a Single-Cell Level

open access: yesFrontiers in Immunology, 2019
CD8+ T cells are important effectors of adaptive immunity against pathogens, tumors, and self antigens. Here, we asked how human cognate antigen-responsive CD8+ T cells and their receptors could be identified in unselected single-cell gene expression ...
Yannick F. Fuchs   +13 more
doaj   +1 more source

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

open access: yesJournal of Clinical Investigation, 2017
Chimeric antigen receptor (CAR) T cells have been highly successful in treating hematological malignancies, including acute and chronic lymphoblastic leukemia.
P. Beavis   +17 more
semanticscholar   +1 more source

Large-scale GPU-based network analysis of the human T-cell receptor repertoire [PDF]

open access: yesarXiv, 2021
Understanding the structure of the human T-cell receptor repertoire is a crucial precondition to understand the ability of the immune system to recognize and respond to antigens. T-cells are often compared via the complementarity determining region 3 (CDR3) of their respective T-cell receptor beta chains.
arxiv  

Detecting T-cell receptors involved in immune responses from single repertoire snapshots [PDF]

open access: yesPLoS Biol 17(6): e3000314 (2019), 2018
Hypervariable T-cell receptors (TCR) play a key role in adaptive immunity, recognising a vast diversity of pathogen-derived antigens. High throughput sequencing of TCR repertoires (RepSeq) produces huge datasets of T-cell receptor sequences from blood and tissue samples.
arxiv   +1 more source

Multiplex T Cell Stimulation Assay Utilizing a T Cell Activation Reporter-Based Detection System

open access: yesFrontiers in Immunology, 2020
Recent advancements in single cell sequencing technologies allow for identification of numerous immune-receptors expressed by T cells such as tumor-specific and autoimmune T cells.
Sarah E. Mann   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy